131 related articles for article (PubMed ID: 35065454)
1. Prognostic impact of Beta-2 Adrenergic Receptor in oral squamous cell carcinoma.
Krishna A; Singh S; Kumar V
Oral Oncol; 2022 Feb; 125():105720. PubMed ID: 35065454
[No Abstract] [Full Text] [Related]
2. Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell carcinoma: an emerging prognostic indicator and future therapeutic target.
Krishna A; Singh V; Singh N; Singh S; Mohanty SK; Singh R; Kumar V; Singh US; Singh RK
Clin Transl Oncol; 2022 Nov; 24(11):2191-2199. PubMed ID: 35918593
[TBL] [Abstract][Full Text] [Related]
3. Expression of β
Santos-Sousa AL; Kayahara GM; Bastos DB; Sarafim-Silva BAM; Crivelini MM; Valente VB; Corrente JE; Xavier-Júnior JCC; Miyahara GI; Bernabé DG
Arch Oral Biol; 2024 Jun; 162():105939. PubMed ID: 38490087
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma.
Bravo-Calderón DM; Oliveira DT; Marana AN; Nonogaki S; Carvalho AL; Kowalski LP
Cancer Biomark; 2011-2012; 10(1):51-9. PubMed ID: 22297552
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of β-Adrenergic Receptors and the Suppressive Effect of β
Zhang C; Liao X; Ma Z; Liu S; Fang F; Mai H
J Oral Maxillofac Surg; 2020 Oct; 78(10):1871.e1-1871.e23. PubMed ID: 32640209
[TBL] [Abstract][Full Text] [Related]
6. Expression of beta2-adrenergic receptor in oral squamous cell carcinoma.
Shang ZJ; Liu K; Liang DF
J Oral Pathol Med; 2009 Apr; 38(4):371-6. PubMed ID: 19141064
[TBL] [Abstract][Full Text] [Related]
7. Glandular metaplasia in oral squamous cell carcinoma: Prognostic indicators? Deriving inference from urothelial and breast carcinoma.
Ramadoss R; Yuwanati M; Ramani P; Krishnan R; Annasamy R
Oral Oncol; 2022 Jan; 124():105639. PubMed ID: 34837728
[No Abstract] [Full Text] [Related]
8. The prognostic impact of micrometastases and isolated tumor cells in early oral squamous cell carcinoma.
de Bree R; Witjes MJH; de Keizer B
Eur Arch Otorhinolaryngol; 2021 Dec; 278(12):5105-5106. PubMed ID: 33386440
[No Abstract] [Full Text] [Related]
9. Can koilocytes without dysplasia in OPMDs be an early indicator and prognostic factor for oral squamous cell carcinoma?
Ramdoss R; Yuwanati M; Viola E A; Ramani P; Murugan MS
Oral Oncol; 2022 Jan; 124():105672. PubMed ID: 34920376
[No Abstract] [Full Text] [Related]
10. The effect of C-reactive protein/albumin ratio on overall survival in patients with oral squamous cell carcinoma: A meta-analysis.
Lu H; Huang MN; Li CY; Tang SJ
Asian J Surg; 2023 Apr; 46(4):1728-1730. PubMed ID: 36283873
[No Abstract] [Full Text] [Related]
11. Association of differential β-catenin expression with Oct-4 and Nanog in oral squamous cell carcinoma and their correlation with clinicopathological factors and prognosis.
Ravindran G; Sawant SS; Hague A; Kingsley K; Devaraj H
Head Neck; 2015 Jul; 37(7):982-93. PubMed ID: 24700702
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of cathepsin L and its inhibitor headpin in oral squamous cell carcinoma.
Nakashima T; Yasumatsu R; Masuda M; Clayman GL; Komune S
J Laryngol Otol; 2012 Nov; 126(11):1134-7. PubMed ID: 22963824
[TBL] [Abstract][Full Text] [Related]
13. Letter to the editor: is HIF-1α a viable prognostic indicator in OSCC? A critical review of a meta-analysis study.
Jayaraj R; Kumarasamy C; Madurantakam Royam M; Devi A; Baxi S
World J Surg Oncol; 2018 Jun; 16(1):111. PubMed ID: 29914529
[TBL] [Abstract][Full Text] [Related]
14. Commentary on 'Relationship of programmed death ligand-1 expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma: A meta-analysis' (He et al., (2020) Archives of Oral Biology, 114, 104717).
Peña-Cardelles JF; Moro-Rodríguez JE; Cebrián-Carretero JL; Pozo-Kreilinger JJ
Arch Oral Biol; 2021 Dec; 132():105274. PubMed ID: 34678606
[No Abstract] [Full Text] [Related]
15. Alteration of serum lipid profile and its prognostic value in head and neck squamous cell carcinoma.
Li G; Da M; Zhang W; Wu H; Ye J; Chen J; Ma L; Gu N; Wu Y; Song X
J Oral Pathol Med; 2016 Mar; 45(3):167-72. PubMed ID: 26189546
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implication of CD57, CD16, and TGF-β expression in oral squamous cell carcinoma.
Taghavi N; Bagheri S; Akbarzadeh A
J Oral Pathol Med; 2016 Jan; 45(1):58-62. PubMed ID: 25808210
[TBL] [Abstract][Full Text] [Related]
17. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
[TBL] [Abstract][Full Text] [Related]
18. Risk Analysis in Oral Squamous Cell Carcinoma: Are We Missing Something?
Troeltzsch M; Otto S
J Oral Maxillofac Surg; 2021 Sep; 79(9):1819-1820. PubMed ID: 34153250
[No Abstract] [Full Text] [Related]
19. β
Mele L; Del Vecchio V; Marampon F; Regad T; Wagner S; Mosca L; Bimonte S; Giudice A; Liccardo D; Prisco C; Schwerdtfeger M; La Noce M; Tirino V; Caraglia M; Papaccio G; Desiderio V; Barbieri A
Cell Death Dis; 2020 Oct; 11(10):850. PubMed ID: 33051434
[TBL] [Abstract][Full Text] [Related]
20. Outcomes for recurrent oral cavity squamous cell carcinoma: A comprehensive outlook.
Reghunadhan P; Hegde S; Thakur S; Subash A; Rao VUS
Oral Oncol; 2023 Aug; 143():106440. PubMed ID: 37290381
[No Abstract] [Full Text] [Related]
[Next] [New Search]
